Kamal Rahmouni Selected Research

Leptin

1/2021	Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.
1/2020	Single-Nucleus RNA Sequencing of the Hypothalamic Arcuate Nucleus of C57BL/6J Mice After Prolonged Diet-Induced Obesity.
1/2019	Celastrol Reduces Obesity in MC4R Deficiency and Stimulates Sympathetic Nerve Activity Affecting Metabolic and Cardiovascular Functions.
4/2017	Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism.
1/2017	The cellular and molecular bases of leptin and ghrelin resistance in obesity.
12/2016	Leptin as a Mediator of Obesity-Induced Hypertension.
2/2016	The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane.
1/2016	Neonatal growth restriction-related leptin deficiency enhances leptin-triggered sympathetic activation and central angiotensin II receptor-dependent stress-evoked hypertension.
9/2015	Effects of leptin on sympathetic nerve activity in conscious mice.
4/2015	Angiotensin type 1a receptors in the forebrain subfornical organ facilitate leptin-induced weight loss through brown adipose tissue thermogenesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kamal Rahmouni Research Topics

Disease

57	Obesity 01/2022 - 02/2002
35	Body Weight (Weight, Body) 11/2021 - 02/2002
25	Hypertension (High Blood Pressure) 01/2021 - 02/2002
13	Insulin Resistance 01/2021 - 01/2004
11	Weight Loss (Weight Reduction) 10/2020 - 04/2002
10	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 01/2022 - 04/2008
8	Weight Gain 12/2019 - 01/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2004
5	AIDS-Related Complex (ARC) 11/2020 - 04/2011
4	Glucose Intolerance 12/2019 - 09/2010
4	Hyperphagia (Overeating) 12/2019 - 11/2007
2	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 09/2010
2	Vascular Ring 10/2019 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2019 - 03/2013
2	Dehydration (Water Stress) 11/2017 - 04/2017
2	Atherosclerosis 01/2017 - 08/2005
2	Type 2 Diabetes Mellitus (MODY) 09/2010 - 11/2006
1	Bardet-Biedl syndrome 1 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2021
1	Albuminuria 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Ketosis 01/2020
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2019
1	Vascular Remodeling 11/2018
1	Glycosuria 10/2017
1	Fatty Liver 01/2017
1	Anorexia 01/2017
1	Stroke (Strokes) 01/2016
1	Polydipsia 01/2016

Drug/Important Bio-Agent (IBA)

39	LeptinIBA 01/2021 - 02/2002
16	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 11/2006
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
13	Hormones (Hormone)IBA 01/2017 - 02/2002
9	Insulin (Novolin)FDA Link 11/2017 - 10/2004
6	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 11/2020 - 07/2010
6	Leptin ReceptorsIBA 01/2019 - 06/2008
5	SaltsIBA 01/2021 - 02/2002
4	AMP-Activated Protein KinasesIBA 01/2022 - 09/2010
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 04/2013
4	fibroblast growth factor 21IBA 01/2021 - 10/2014
4	Angiotensin IIIBA 01/2020 - 04/2015
4	LipidsIBA 01/2019 - 10/2004
3	Steroidogenic Factor 1IBA 10/2021 - 11/2018
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 09/2014
3	Peptides (Polypeptides)IBA 11/2020 - 04/2017
3	MelanocortinsIBA 11/2020 - 11/2007
3	AngiotensinsIBA 04/2017 - 04/2015
3	Phosphotransferases (Kinase)IBA 06/2015 - 12/2008
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2021 - 01/2019
2	Nicotine FDA Link 01/2021 - 01/2019
2	ReninIBA 01/2020 - 12/2016
2	Sirtuin 1IBA 12/2019 - 07/2010
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2018 - 12/2016
2	Acetates (Acetic Acid Esters)FDA Link 11/2017 - 02/2002
2	Desoxycorticosterone (Deoxycorticosterone)IBA 11/2017 - 02/2002
2	Pharmaceutical PreparationsIBA 10/2017 - 03/2015
2	Drinking WaterIBA 04/2017 - 12/2014
2	mitoquinoneIBA 04/2017 - 12/2014
2	GhrelinIBA 01/2017 - 01/2005
2	Insulin ReceptorIBA 11/2016 - 06/2015
2	Sirolimus (Rapamycin)FDA Link 01/2016 - 04/2015
2	AngiotensinogenIBA 03/2007 - 06/2004
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Bone Morphogenetic Protein ReceptorsIBA 01/2022
1	Endothelial Growth FactorsIBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	Orexin ReceptorsIBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	SodiumIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021
1	anandamide (arachidonylethanolamide)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2019
1	Tamoxifen FDA LinkGeneric 10/2019
1	tempolIBA 01/2019
1	celastrolIBA 01/2019
1	Phenol (Carbolic Acid)FDA Link 01/2019
1	Cullin Proteins (Cullins)IBA 01/2019
1	NeuregulinsIBA 11/2018
1	CytokinesIBA 07/2017
1	beta Adrenergic ReceptorsIBA 01/2017
1	AcidsIBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	CarbohydratesIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2016
1	MyostatinIBA 03/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Rosiglitazone (Avandia)FDA Link 01/2016

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2005
1	Intravenous Injections 10/2021
1	Sympathectomy (Sympathectomies) 01/2019
1	Denervation 10/2017
1	Ketogenic Diet 01/2017
1	Vagus Nerve Stimulation 01/2016